GeneDx Holdings Corp.
WGS
$166.95
$1.340.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 393.30M | 357.20M | 326.81M | 302.16M | 263.18M |
| Total Other Revenue | 8.89M | 5.13M | 3.33M | 3.29M | 4.05M |
| Total Revenue | 402.19M | 362.32M | 330.14M | 305.45M | 267.23M |
| Cost of Revenue | 122.08M | 118.90M | 114.68M | 111.00M | 108.23M |
| Gross Profit | 280.11M | 243.42M | 215.47M | 194.45M | 159.00M |
| SG&A Expenses | 208.74M | 184.74M | 180.50M | 169.56M | 165.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 785.00K | 785.00K | 785.00K | 785.00K | 687.00K |
| Total Operating Expenses | 390.53M | 355.18M | 342.54M | 326.91M | 317.17M |
| Operating Income | 11.66M | 7.14M | -12.40M | -21.46M | -49.94M |
| Income Before Tax | 2.51M | 1.54M | -38.39M | -52.63M | -84.23M |
| Income Tax Expenses | 424.00K | 130.00K | 186.00K | -343.00K | -730.00K |
| Earnings from Continuing Operations | 2.08 | 1.41 | -38.58 | -52.29 | -83.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.08M | 1.41M | -38.58M | -52.29M | -83.50M |
| EBIT | 11.66M | 7.14M | -12.40M | -21.46M | -49.94M |
| EBITDA | 34.66M | 29.60M | 9.08M | -408.00K | -23.65M |
| EPS Basic | 0.08 | 0.04 | -1.44 | -1.98 | -3.17 |
| Normalized Basic EPS | 0.46 | 0.37 | -0.57 | -0.92 | -1.79 |
| EPS Diluted | 0.06 | 0.02 | -1.44 | -1.99 | -3.18 |
| Normalized Diluted EPS | 0.45 | 0.36 | -0.57 | -0.92 | -1.79 |
| Average Basic Shares Outstanding | 113.31M | 111.61M | 109.65M | 107.56M | 105.69M |
| Average Diluted Shares Outstanding | 114.48M | 112.78M | 109.65M | 107.56M | 105.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |